Evidence map›Paper›PMID 40998727›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

OpenDose3D: A Free, Open-Source Clinical Dosimetry Software for Patient-Specific Dosimetry.

José-Alejandro Fragoso-Negrín, Alex Vergara-Gil, Assyifa Rahman Hakim, Deni Hardiansyah, Gerhard Glatting, Ludovic Ferrer, Nicolas Varmenot, Lore Santoro, Susana Veloza-Awad, Kevin Hébert and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

José-Alejandro Fragoso-NegrínInstitut de Recherche en Cancérologie de Montpellier, Équipe Labellisée Ligue Contre le Cancer, INSERM U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier, France.
Alex Vergara-GilBIOMEDIQA GROUPE, Villeneuve-d'Ascq, France.
Assyifa Rahman HakimMedical Physics and Biophysics, Physics Department, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Depok, Indonesia.
Deni HardiansyahMedical Physics and Biophysics, Physics Department, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Depok, Indonesia.
Gerhard GlattingMedical Radiation Physics, Department of Nuclear Medicine, Ulm University, Ulm, Germany; and.
Ludovic FerrerMedical Physics Department, ICO René Gauducheau, Nantes, France.
Nicolas VarmenotMedical Physics Department, ICO René Gauducheau, Nantes, France.
Lore SantoroInstitut de Recherche en Cancérologie de Montpellier, Équipe Labellisée Ligue Contre le Cancer, INSERM U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier, France.
Susana Veloza-AwadInstitut de Recherche en Cancérologie de Montpellier, Équipe Labellisée Ligue Contre le Cancer, INSERM U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier, France.
Kevin HébertNuclear Medicine Department, Institut Régional du Cancer de Montpellier, Montpellier, France.
Emmanuel DeshayesInstitut de Recherche en Cancérologie de Montpellier, Équipe Labellisée Ligue Contre le Cancer, INSERM U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier, France.
Manuel BardièsInstitut de Recherche en Cancérologie de Montpellier, Équipe Labellisée Ligue Contre le Cancer, INSERM U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier, France; manuel.bardies@inserm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Software tools for nuclear medicine dosimetry are becoming available. Yet, it is difficult to compare clinical dosimetry workflows implemented in academic or commercial software tools, and this limits the emergence of a standardized clinical dosimetry practice. This article introduces OpenDose3D (OD3D), an open-source software designed to provide image-based, patient-specific dosimetry in nuclear medicine. OD3D implements multiple clinical dosimetry workflows and exports intermediate results, enabling comparison between various dosimetry approaches.

Indexed as

Nuclear MedicineRadiometrySoftwareHumansPhantoms, Imagingclinical dosimetry workflowsopen-source softwarepatient-specific dosimetryradionuclide therapyresearch methods

Identifiers

PMID40998727
PMCPMC12866356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.